Home/Filings/4/0000899243-23-013903
4//SEC Filing

Schwartz Jeffrey Lawrence 4

Accession 0000899243-23-013903

CIK 0001773427other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 5:04 PM ET

Size

9.2 KB

Accession

0000899243-23-013903

Insider Transaction Report

Form 4
Period: 2023-05-24
Schwartz Jeffrey Lawrence
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-24+13,77413,774 total
    Exercise: $32.27Exp: 2033-05-24Common Stock (13,774 underlying)
  • Award

    Common Stock

    2023-05-24+4,64810,572 total
Holdings
  • Common Stock

    (indirect: See footnote)
    3,081,307
Footnotes (4)
  • [F1]This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders. The RSUs shall vest in full on the earlier of (1) May 24, 2024 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.
  • [F2]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders.
  • [F3]The options shall vest in full on the earlier of (1) May 24, 2024 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.
  • [F4]Represents shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. The Reporting Person is a Partner of BCLSI. As a result, the Reporting Person may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Issuer

SpringWorks Therapeutics, Inc.

CIK 0001773427

Entity typeother

Related Parties

1
  • filerCIK 0001702957

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:04 PM ET
Size
9.2 KB